Skip to main content

Table 2 Data of stage IB1 and IIA1 patients before and after matching

From: Comparison of survival outcomes between radio-chemotherapy and radical hysterectomy with postoperative standard therapy in patients with stage IB1 to IIA2 cervical cancer: long-term oncological outcome analysis in 37 Chinese hospitals

VariablesUnmatchedMatched
R-CT (n = 321)RH (n = 3755)p-valueR-CT (n = 300)RH (n = 300)p-value
Age (years)58.9 ± 10.848.0 ± 9.80.00057.7 ± 10.057.5 ± 9.80.874
FIGO stage  0.000  1.000
 IB184 (26.2%)2770 (73.8%) 81 (27.0%)81 (27.0%) 
 IIA1237 (73.8%)985 (26.3%) 219 (73.0%)219 (73.0%) 
Histological type  0.000  1.000
 SCC308 (96.0%)3350 (89.2%) 288 (96.0%)288 (96.0%) 
 AC9 (2.8%)310 (8.3%) 8 (2.7%)8 (2.7%) 
 SAC4 (1.2%)95 (2.5%) 4 (1.3%)4 (1.3%) 
Tumour size  0.000  1.000
  > 4 cm60 (18.7%)470 (12.5%) 58 (19.3%)58 (19.3%) 
  ≤ 4 cm261 (81.3%)3285 (87.5%) 242 (80.7%)242 (80.7%) 
  1. R-CT radio-chemotherapy, RH radical hysterectomy with postoperative standard therapy, FIGO International Federation of Gynecology and Obstetrics, SCC squamous cell carcinoma, AC adenocarcinoma, SAC adenosquamous carcinoma